Drug intelligence / Profile preview

Xiao'er Zhixie gel

Development stage: Unknown
Lead developer: Gansu Duyiwei Pharmaceutical
Administration: Topical

Overview

Xiao'er Zhixie gel is a pediatric Traditional Chinese Medicine (TCM) herbal formulation developed by Gansu Duyiwei Biological Pharmaceutical for the treatment of rotavirus-induced diarrhea. It is specifically indicated for children aged 0.5 to 4 years who exhibit the "cold-damp" pattern according to TCM diagnostics. The product is a gel intended for topical application, often used as an adjunctive therapy to standard rehydration and care. Clinical development has reached Phase II in China, focusing on its safety and efficacy in reducing the duration of diarrhea and improving clinical symptoms associated with rotavirus gastroenteritis.

Brand names: Xiao'er Zhixie gel
Other names: Pediatric Antidiarrheal Gel

Targets

COXmAChR (Muscarinic acetylcholine receptors)

Beyond the preview

Go deeper on Xiao'er Zhixie gel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xiao'er Zhixie gel.

Explore the full profile